Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)

Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)

Bibliographic Details
Main Author:	Ji Hye Huh
Format:	Article
Language:	English
Published:	Korean Diabetes Association 2022-11-01
Series:	Diabetes & Metabolism Journal
Online Access:	http://e-dmj.org/upload/pdf/dmj-2022-0374.pdf

Similar Items

Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
by: Da Hea Seo, et al.
Published: (2022-11-01)

Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802)
by: Se Hee Min
Published: (2022-09-01)

Association between Type 2 Diabetes Mellitus and Brain Atrophy: A Meta-Analysis (Diabetes Metab J 2022;46:781-802)
by: Tianqi Zhang, et al.
Published: (2022-09-01)

Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus (Diabetes Metab J 2022;46:93-103)
by: Gyuri Kim
Published: (2022-05-01)

Association between Metabolic Syndrome and Microvascular Complications in Chinese Adults with Type 1 Diabetes Mellitus (Diabetes Metab J 2022;46:93-103)
by: Qianwen Huang, et al.
Published: (2022-05-01)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
by: Eugene Han, et al.
Published: (2021-11-01)

The Determinants of Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: Chia-Yen Dai, et al.
Published: (2022-06-01)

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
by: Tomoyuki Kawada
Published: (2022-07-01)

Clinical Efficacy of Sodium-Glucose Cotransporter 2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy in Type 2 Diabetes Mellitus: Real-World Study (Diabetes Metab J 2022;46: 658-62)
by: Hwi Seung Kim, et al.
Published: (2022-07-01)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707)
by: Mi-kyung Kim
Published: (2021-11-01)

Nonalcoholic fatty liver disease and Type 2 diabetes mellitus
by: Mala Dharmalingam, et al.
Published: (2018-01-01)

Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency
by: I G Bakulin, et al.
Published: (2017-02-01)

Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
by: Da Hea Seo, et al.
Published: (2022-07-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17)
by: Eun Roh
Published: (2023-03-01)

Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography (Diabetes Metab J 2023;47:104-17)
by: Hwi Seung Kim, et al.
Published: (2023-03-01)

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: Marcin Kosmalski, et al.
Published: (2022-03-01)

Change in Liver Fibrosis Associates with Progress of Diabetic Nephropathy in Patients with Nonalcoholic Fatty Liver Disease
by: Yoshiko Terasaka, et al.
Published: (2023-07-01)

Impact of Diabetes Mellitus and Insulin on Nonalcoholic Fatty Liver Disease in the Morbidly Obese
by: Claudia B.M. Strey, et al.
Published: (2018-07-01)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
by: Waseem Amjad, et al.
Published: (2023-08-01)

Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
by: Eugene Han, et al.
Published: (2021-09-01)

Histological changes in the liver of diabetic rats: A review of pathogenesis of nonalcoholic fatty liver disease in type 1 diabetes mellitus
by: Hafiz Muhammad Bilal, et al.
Published: (2016-12-01)

Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
by: Eun-Jung Rhee
Published: (2019-09-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

Elevated Serum Cyclophilin D Level is Associated with Nonalcoholic Fatty Liver Disease and Higher Fibrosis Scores in Patients with Diabetes Mellitus
by: Naguib M, et al.
Published: (2021-08-01)

Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Waist Circumference and Body Mass Index Variability and Incident Diabetic Microvascular Complications: A Analysis of ACCORD Trial ( 2022;46:767-80)
by: Daniel Nyarko Hukportie, et al.
Published: (2023-01-01)

Waist Circumference and Body Mass Index Variability and Incident Diabetic Microvascular Complications: A Analysis of ACCORD Trial ( 2022;46:767-80)
by: Yun Kyung Cho
Published: (2023-01-01)

Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis
by: D.N. Amarapurkar, et al.
Published: (2006-01-01)

Mechanism of TangGanJian on nonalcoholic fatty liver disease with type 2 diabetes mellitus
by: Yanbo Fan, et al.
Published: (2018-01-01)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
by: Stefano Ciardullo, et al.
Published: (2021-07-01)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
by: Hideki Fujii, et al.
Published: (2020-05-01)

Nonalcoholic fatty liver disease in patients with type 2 diabetes
by: N. A. Petunina, et al.
Published: (2016-12-01)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
by: Kyung-Soo Kim, et al.
Published: (2019-04-01)

Liver Stiffness Measurement is Useful in Predicting Type 2 Diabetes Mellitus Among Nonalcohol Fatty Liver Disease Patients
by: Ding Y, et al.
Published: (2024-01-01)

Role of mast cells in the pathogenesis of liver fibrosis in nonalcoholic fatty liver disease
by: Ewa Lewandowska, et al.
Published: (2020-05-01)

NONALCOHOLIC FATTY LIVER DISEASE: COMORBIDITIES, CLINICAL SIGNIFICANCE AND EVALUATION OF LIVER FIBROSIS
by: D. V. Marshalko, et al.
Published: (2018-02-01)

Resistin as a Marker of Liver Function Disorder in Combined Course of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: L.V. Zhuravliova, et al.
Published: (2015-09-01)

Relationship between Ectodysplasin A and Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
by: QIAN Fangfang, CAI Zhensheng, GU Tian, LI Haoxiang, ZHAO Li, YANG Ling, DENG Xia, YUAN Guoyue
Published: (2023-03-01)

The Perirenal Fat Thickness Was Associated with Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus
by: Yang Y, et al.
Published: (2022-05-01)

Nonalcoholic fatty liver disease and early prediction of gestational diabetes mellitus using machine learning methods
by: Seung Mi Lee, et al.
Published: (2022-01-01)